157 related articles for article (PubMed ID: 15089791)
1. Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK.
Shearer A; Bagust A; Sanderson D; Heller S; Roberts S
Diabet Med; 2004 May; 21(5):460-7. PubMed ID: 15089791
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model.
Kruger J; Brennan A; Thokala P; Basarir H; Jacques R; Elliott J; Heller S; Speight J
Diabet Med; 2013 Oct; 30(10):1236-44. PubMed ID: 23815547
[TBL] [Abstract][Full Text] [Related]
3. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial.
DAFNE Study Group
Diabet Med; 2003 Jun; 20 Suppl 3():4-5. PubMed ID: 12786669
[No Abstract] [Full Text] [Related]
4. [The study of development and progression of long-term complications in type I diabetes].
Araki E; Matsumura T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
[No Abstract] [Full Text] [Related]
5. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
6. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
St Charles ME; Sadri H; Minshall ME; Tunis SL
Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
8. COST-EFFECTIVENESS OF STRUCTURED EDUCATION IN CHILDREN WITH TYPE-1 DIABETES MELLITUS.
Basarir H; Brennan A; Jacques R; Pollard D; Stevens K; Freeman J; Wales J; Price K
Int J Technol Assess Health Care; 2016 Jan; 32(4):203-211. PubMed ID: 27719689
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
CDC Diabetes Cost-effectiveness Group
JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
[No Abstract] [Full Text] [Related]
11. The Diabetes Control and Complications Trial: new challenges for the primary physician.
Clarke WL
Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
[No Abstract] [Full Text] [Related]
12. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.
DAFNE Study Group
BMJ; 2002 Oct; 325(7367):746. PubMed ID: 12364302
[TBL] [Abstract][Full Text] [Related]
13. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.
Sämann A; Mühlhauser I; Bender R; Kloos Ch; Müller UA
Diabetologia; 2005 Oct; 48(10):1965-70. PubMed ID: 16132954
[TBL] [Abstract][Full Text] [Related]
14. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
15. How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients' self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course.
Rankin D; Cooke DD; Clark M; Heller S; Elliott J; Lawton J;
Diabet Med; 2011 May; 28(5):532-8. PubMed ID: 21244477
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.
Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC
Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes].
Nørgaard K; Sohlberg A; Goodall G
Ugeskr Laeger; 2010 Jul; 172(27):2020-5. PubMed ID: 20594535
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
20. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
